Guideline
doi: 10.1046/j.1365-2516.2003.00711.x.
Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders
- PMID: 12558775
- DOI: 10.1046/j.1365-2516.2003.00711.x
Item in Clipboard
Guideline
Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders
Haemophilia.
2003 Jan.
Abstract
Evidence based guidelines are presented on the selection and use of therapeutic products to treat haemophilia. These guidelines offer advice based on the best published scientific and medical information. They will be reviewed regularly by UKHCDO Advisory Committee. Included are details of therapeutic products available in the UK to treat patients with haemophilia and other bleeding disorders and the background information on which the recommendations are based are presented.
Similar articles
-
Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.Haemophilia. 2008 Jul;14(4):671-84. doi: 10.1111/j.1365-2516.2008.01695.x. Epub 2008 Apr 4. Haemophilia. 2008. PMID: 18422612
-
Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.CMAJ. 1995 Jul 15;153(2):147-57. CMAJ. 1995. PMID: 7600466 Free PMC article.
-
Switching haemophilia products and inhibitor risk: a United States' perspective.Eur J Haematol. 2015 Apr;94(4):283. doi: 10.1111/ejh.12441. Eur J Haematol. 2015. PMID: 25800968 No abstract available.
-
Joint WFH-ISTH session: issues in clinical trial design.Haemophilia. 2014 May;20 Suppl 4:137-44. doi: 10.1111/hae.12415. Haemophilia. 2014. PMID: 24762289 Review.
-
Pioneering designs for recombinant coagulation factors.Thromb Res. 2011;128 Suppl 1:S9-12. doi: 10.1016/S0049-3848(12)70003-8. Thromb Res. 2011. PMID: 22221848 Review.
Cited by
-
Early Fresh Frozen Plasma Transfusion: Is It Associated With Improved Outcomes of Patients With Sepsis?Front Med (Lausanne). 2021 Nov 16;8:754859. doi: 10.3389/fmed.2021.754859. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34869452 Free PMC article.
-
Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy.Blood Transfus. 2007 Nov;5(4):204-9. doi: 10.2450/2007.0023-07. Blood Transfus. 2007. PMID: 19204776 Free PMC article.
-
Immune tolerance induction for patients with severe hemophilia A: a critical literature review.J Thromb Thrombolysis. 2011 Nov;32(4):439-47. doi: 10.1007/s11239-011-0624-3. J Thromb Thrombolysis. 2011. PMID: 21818664 Review.
-
Fibrinogen concentrate in bleeding patients.Cochrane Database Syst Rev. 2013 Aug 29;2013(8):CD008864. doi: 10.1002/14651858.CD008864.pub2. Cochrane Database Syst Rev. 2013. PMID: 23986527 Free PMC article.
-
Sucrose-formulated octocog alfa: a review of its use in patients with haemophilia A.Drugs. 2008;68(6):839-53. doi: 10.2165/00003495-200868060-00007. Drugs. 2008. PMID: 18416588 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
